NCT03480607View on ClinicalTrials.gov

Dexmedetomidine as Adjuvant for Bupivacaine in Ultrasound Guided Infraorbital Nerve Block for Cleft Lip Repair

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

April 30, 2018

Study Completion Date

May 10, 2018

Conditions
Cleft Lip
Interventions
DRUG

Dexmedetomidine group

0.75 ml of 0.5% Bupivacaine in conjunction with 0.5 mcg/kg dexmedetomidine

DRUG

Dexamethasone group

0.75 ml of 0.5% Bupivacaine in conjunction with 0.1 mcg/kg dexamethasone

Trial Locations (1)

050

Mansoura University Childeren Hospital, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT03480607 - Dexmedetomidine as Adjuvant for Bupivacaine in Ultrasound Guided Infraorbital Nerve Block for Cleft Lip Repair | Biotech Hunter | Biotech Hunter